Search Results1-9 of  9

  • IDE Kazuhiko ID: 9000001859428

    Department of Hematology, Kumamoto University School of Medicine (2007 from CiNii)

    Articles in CiNii:1

    • Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma (2007)
  • IDE Kazuhiko ID: 9000004886409

    Toshiba Corporation Research & Development Center (2005 from CiNii)

    Articles in CiNii:2

    • Wavelength Lock System Using a Quartz Etalon Supported at the Middle Point(Fiber-Optic Transmission for Communications) (2005)
    • Ultra-Dense WDM with over 100% Spectral Efficiency Using Co-polarized 40-Gb/s Inverse-RZ Signals (2005)
  • IDE Kazuhiko ID: 9000004891167

    TOSHIBA Corporate Research & Development Center (2006 from CiNii)

    Articles in CiNii:24

    • Ultra-high dense WDM of Inverse-RZ signals (2003)
    • An optical node utilizing optical ADM and tuning laser : Examination on optical node for DWDM transmission (2006)
    • Optical IP-VPN using Fast Wavelength Tunable Laser Diode (2006)
  • IDE Kazuhiko ID: 9000005002950

    Computer & Network Development Center, Digital Media Equipment & Service Company, TOSHIBA Corp. (1999 from CiNii)

    Articles in CiNii:1

    • A novel monitoring method of optical signal quality using amplitude probability distribution (1999)
  • IDE Kazuhiko ID: 9000018805077

    Faculty of Science, Toho University (2011 from CiNii)

    Articles in CiNii:2

    • Voice Revitalization Analysis in Tele-coaching (2011)
    • Voice Revitalization Analysis in Tele-coaching (2011)
  • Ide Kazuhiko ID: 9000004920048

    TOSHIBA Corporation HINO Operations (2000 from CiNii)

    Articles in CiNii:3

    • 10Gbps high sensitivity PIN-HEMT optical receiver module (1998)
    • Development of the large scale Rate-Free Matrix (2000)
    • 11-3 Rate-Free Matrix (1999)
  • Ide Kazuhiko ID: 9000021739644

    Articles in CiNii:1

    • TV Network for Broadcasting of Tokyo Olympic Games in Japan (1965)
  • Ide Kazuhiko ID: 9000024753638

    Articles in CiNii:1

    • Potent activity of a nucleoside reverse transcriptase inhibitor, 4′-ethynyl-2-fluoro-2′-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase 3 knockout mice (2009)
Page Top